C. J. Woolf and S. W. Thompson, “The Induction and Maintenance of Central Sensitization Is Dependent on N-Methyl-D-Aspartic Receptor Activation; Implications for the Treatment of Post-Injury Pain Hypersensitivity States,” Pain, Vol. 44, No. 3, 1991, pp. 293-299. doi:10.1016/0304-3959(91)90100-C

has been cited by the following article:

• TITLE: Early and Late Postoperative Pain and Side Effects after Mastectomy: A Comparison of Ketamine and Thiamylal Administered for Anesthetic Induction

  AUTHORS: Tadasuke Use, Tetsuya Sakai, Hiroko Shimamoto, Taku Fukano, Koji Sumikawa

  KEYWORDS: Preventive Analgesia; Ketamine; Mastectomy; Postoperative Pain; Anesthetic Induction

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.3 No.3, May 24, 2013

  ABSTRACT: Objective: To compare acute and long-term postoperative pain and side effects in patients undergoing mastectomy for breast cancer under general anesthesia induced with ketamine or thiamylal. Methods: Twenty four ASA physical status I-III patients undergoing mastectomy were randomly assigned to one of two groups. Ketamine group received intravenous ketamine, 1 mg/kg, and thiamylal group received intravenous thiamylal, 4 mg/kg, at the induction of general anesthesia. Anesthesia was maintained with sevoflurane, N2O and fentanyl. The intensity of pain was assessed by using visual analog scale (VAS) 3 and 16 hr and 2, 3 and 4 weeks after surgery. Postoperative side effects, including nausea, vomiting and hallucination were also recorded. Results: At 16 hr after surgery, VAS in ketamine group was significantly lower than that in thiamylal group. However, there were no statistically significant differences between the two groups in the VAS at 3 hr and 2, 3 and 4 weeks after surgery. There were no differences in the incidence of side effects such as nausea, vomiting and hallucination between the two groups. Conclusion: Intravenous ketamine at the induction of anesthesia could reduce acute postoperative pain but not long-term pain after mastectomy.